Medicare Advantage and Type 2 Diabetes Outcomes.

Berkowitz SA, LaPoint M, Kuhn ML, Basu S, Hudgens MG, Gold R, Park S

Open source

DOI
10.1001/jamainternmed.2026.3332
Published
2026 Aug 10
Container
JAMA internal medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamainternmed.2026.3332,
  title = {Medicare Advantage and Type 2 Diabetes Outcomes.},
  author = {Berkowitz SA and LaPoint M and Kuhn ML and Basu S and Hudgens MG and Gold R and Park S},
  year = {2026},
  journal = {JAMA internal medicine},
  doi = {10.1001/jamainternmed.2026.3332},
  url = {https://doi.org/10.1001/jamainternmed.2026.3332}
}

RIS

TY  - JOUR
TI  - Medicare Advantage and Type 2 Diabetes Outcomes.
AU  - Berkowitz SA
AU  - LaPoint M
AU  - Kuhn ML
AU  - Basu S
AU  - Hudgens MG
AU  - Gold R
AU  - Park S
PY  - 2026
JO  - JAMA internal medicine
DO  - 10.1001/jamainternmed.2026.3332
UR  - https://doi.org/10.1001/jamainternmed.2026.3332
ER  - 

APA

SA, B., M, L., ML, K., S, B., MG, H., R, G., & S, P. (2026). Medicare Advantage and Type 2 Diabetes Outcomes.. JAMA internal medicine. https://doi.org/10.1001/jamainternmed.2026.3332

Source records